Balint Szilagyi

Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial

Bruce Strober, Yayoi Tada, Ulrich Mrowietz et al. · British Journal of Dermatology · 2023 · 38 citations · Full text

Connecting liver and gut: Murine liver sinusoidal endothelium induces gut tropism of CD4+ T cells via retinoic acid

Katrin Neumann, Nils Kruse, Balint Szilagyi et al. · Hepatology · 2011 · 37 citations · Full text

Retinoic acid‐induced gut tropism improves the protective capacity of Treg in acute but not in chronic gut inflammation

Astrid Menning, Christoph Loddenkemper, Astrid M. Westendorf et al. · European Journal of Immunology · 2010 · 37 citations · Full text

Chronic Inflammatory Diseases, T-regulatory Cell, Immunology +19

Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis

Matthias Augustin, Alice B. Gottlieb, Mark Lebwohl et al. · Dermatology and Therapy · 2024 · 16 citations · Full text

Bimekizumab efficacy and safety through 3 years in patients with moderate-to-severe plaque psoriasis: long-term results from the BE RADIANT phase IIIb trial open-label extension period

Richard B. Warren, Mark Lebwohl, Diamant Thaçi et al. · British Journal of Dermatology · 2025 · 10 citations · Full text